Are Nursing Home Residents With Dementia Appropriately Treated for Fracture Prevention?
Joshua D Niznik, Xintong Li, Meredith A Gilliam and 4 others
PMID 33321079WHAT IT FOUND
Only 11.6% of nursing home residents with dementia and high fracture risk received fracture prevention medication.
Treatment was less common with severe dementia, pressure ulcers, or limited prognosis, and more common with osteoporosis, mobility devices, or steroids.
Key findings
01Only 11.6% (n=8,420) of nursing home residents with dementia and high fracture risk received fracture prevention medication.
02Treatment was less likely among residents with severe dementia, incontinence, diabetes, pressure ulcers, osteoarthritis, end-stage renal disease, heart failure, mechanically altered diet, benzodiazepines, or alpha blockers.
03An osteoporosis diagnosis was the strongest factor associated with receiving treatment, and walker or wheelchair use, other bone disorders, steroids, proton pump inhibitors, and more than 5 medications were also associated with treatment.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This was an observational claims study, so it cannot show that any factor caused prescribing or that treatment prevented fractures. The medication window included the year before assessment and 90 days after it, so it may count prescriptions that were not continued and may measure some resident characteristics after treatment. The study could not see goals of care, why clinicians chose or stopped medication, or whether low treatment was thoughtful deprescribing. Over-the-counter calcium and vitamin D were not captured. Bedbound residents could not be identified from the MDS. Skilled nursing facility stays were excluded because medication administration data were unavailable. Fracture risk was based on prior fracture or FRAiL score, not bone density.
Declared interests
The authors reported no conflicts of interest. Funding sources had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish.
The easy way to misread this
Do not read the 11.6% treatment rate as proof that most high-risk residents were undertreated. The study reports prescribing patterns, not fracture outcomes, and cannot tell whether treatment was appropriate, omitted, or deliberately stopped for goals of care.